Methyl Alcohol

Methyl Alcohol

SCHEMBL135872

CCCCCCCCS(=O)(=O)[O-].CO.[Na+]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Methyl Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 1/20 0.45
EPHX2 P34913 2/20 0.56
FAAH O00519 4/20 0.50
RECQL P46063 2/20 0.48
TSHR P16473 2/20 0.48
MAPK1 P28482 2/20 0.48
GLA P06280 1/20 0.48
HPGD P15428 1/20 0.48
BLM P54132 1/20 0.48
GMNN O75496 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
THPO P40225 1/20 0.46
HBB P68871 1/20 0.46
PMP22 Q01453 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
BBOX1 O75936 2/20 0.43
CES1 P23141 6/20 0.42
CES2 O00748 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL10778854 1.00 EPHX2 (0.56) EPHX2FAAHRECQLTSHRMAPK1
Methyl Alcohol SCHEMBL27780506 1.00 EPHX2 (0.56) EPHX2FAAHRECQLTSHRMAPK1
Methyl Alcohol SCHEMBL25250336 1.00 EPHX2 (0.56) EPHX2FAAHRECQLTSHRMAPK1
Methyl Alcohol SCHEMBL284907 1.00 EPHX2 (0.56) EPHX2FAAHRECQLTSHRMAPK1
SCHEMBL22390665 0.95 EPHX2 (0.54) EPHX2FAAHRECQLTSHRMAPK1
SCHEMBL22390768 0.95 EPHX2 (0.54) EPHX2FAAHRECQLTSHRMAPK1
SCHEMBL22390657 0.95 EPHX2 (0.54) EPHX2FAAHRECQLTSHRMAPK1
SCHEMBL22390628 0.95 EPHX2 (0.54) EPHX2FAAHRECQLTSHRMAPK1
SCHEMBL22390671 0.95 EPHX2 (0.54) EPHX2FAAHRECQLTSHRMAPK1
SCHEMBL22390625 0.95 EPHX2 (0.54) EPHX2FAAHRECQLTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11692022-B2 Thiosuccinyl-crosslinked hemoglobin analogs and methods of use and preparation thereof BILLION KING INTERNATIONAL LIMITED (CN) 2023-07-04 US disclosed
US-20230111100-A1 Thiosuccinyl-crosslinked Hemoglobin Analogs and Methods of Use and Preparation Thereof BILLION KING INTERNATIONAL LIMITED (HK) 2023-04-13 US disclosed
US-20210061885-A1 Thiosuccinyl-crosslinked Hemoglobin Analogs and Methods of Use and Preparation Thereof BILLION KING INTERNATIONAL LIMITED (CN) 2021-03-04 US disclosed
US-20120058511-A1 MUTANT MICROORGANISM AND METHOD FOR PRODUCING PEPTIDE USING THE SAME AJINOMOTO CO., INC., (JP) 2012-03-08 US disclosed
US-20050176150-A1 Mutant microorganism and method for producing peptide using the same AJINOMOTO CO., INC. (JP) 2005-08-11 US disclosed
EP-1561810-A2 Mutant microorganism and method for producing peptide using the same Ajinomoto Co., Inc. (JP) 2005-08-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210061885-A1 Thiosuccinyl-crosslinked Hemoglobin Analogs and Methods of Use and Preparation Thereof HBG1, HBG2, HBB CA2 3321/4885EPHX2 889/4885FAAH 3547/4885
US-11692022-B2 Thiosuccinyl-crosslinked hemoglobin analogs and methods of use and preparation thereof HBG1, HBG2, HBB CA2 3321/4885EPHX2 889/4885FAAH 3547/4885
US-20230111100-A1 Thiosuccinyl-crosslinked Hemoglobin Analogs and Methods of Use and Preparation Thereof HBG1, HBG2, HBB CA2 3321/4885EPHX2 889/4885FAAH 3547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.